Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Atenza XL 18mg tablets
0404000M0BQADAM
|
Atenza | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Atenza XL 27mg tablets
0404000M0BQACAT
|
Atenza | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Atenza XL 36mg tablets
0404000M0BQABAN
|
Atenza | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Atenza XL 54mg tablets
0404000M0BQAAAR
|
Atenza | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Athiam 50mg tablets
0906026M0BJABAF
|
Athiam | Thiamine hydrochloride | Nutrition and Blood | No data available |
|
Athlete Foot 1% cream
131002030BDAAAA
|
Athlete Foot | Terbinafine hydrochloride | Skin | No data available |
|
Atmocol pocket deodorant spray
23451454501
|
Atmocol pocket deodorant spray | Deodorants | Stoma Appliances | No data available |
|
ATOMAID 100mg capsules
0404000S0BCAAAH
|
ATOMAID | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
ATOMAID 10mg capsules
0404000S0BCAGAA
|
ATOMAID | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
ATOMAID 18mg capsules
0404000S0BCAFAC
|
ATOMAID | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
ATOMAID 25mg capsules
0404000S0BCAEAD
|
ATOMAID | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
ATOMAID 40mg capsules
0404000S0BCADAB
|
ATOMAID | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
ATOMAID 60mg capsules
0404000S0BCACAE
|
ATOMAID | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
ATOMAID 80mg capsules
0404000S0BCABAF
|
ATOMAID | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
Atomoxetine 30mg/5ml oral suspension
0404000S0AAAPAP
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
Atomoxetine 36mg/5ml oral suspension
0404000S0AAAQAQ
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
Atomoxetine 40mg/5ml oral suspension
0404000S0AAAJAJ
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
Atomoxetine 5mg/5ml oral solution
0404000S0AAAGAG
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
Atomoxetine 5mg/5ml oral suspension
0404000S0AAAMAM
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
Atomoxetine 60mg/5ml oral solution
0404000S0AAANAN
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
Atopiclair lotion
21220000202
|
Atopiclair lotion | Emollients | Appliances | No data available |
|
Atorvastatin 40mg/5ml oral liquid
0212000B0AAAGAG
|
Atorvastatin | Atorvastatin | Cardiovascular System | No data available |
|
Atorvastatin 80mg/5ml oral suspension
0212000B0AAAIAI
|
Atorvastatin | Atorvastatin | Cardiovascular System | No data available |
|
Atosiban 37.5mg/5ml solution for infusion vials
0701030V0AAABAB
|
Atosiban | Atosiban | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Atosiban 6.75mg/0.9ml inj pre-filled syringes
0701030V0AAADAD
|
Atosiban | Atosiban | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.